Skip to Content
Merck
CN
  • CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

PloS one (2010-12-03)
Lumine Matsumoto, Hiroshi Takuma, Akira Tamaoka, Hiroshi Kurisaki, Hidetoshi Date, Shoji Tsuji, Atsushi Iwata
ABSTRACT

Alpha-synuclein (SNCA) gene expression is an important factor in the pathogenesis of Parkinson's disease (PD). Gene multiplication can cause inherited PD, and promoter polymorphisms that increase SNCA expression are associated with sporadic PD. CpG methylation in the promoter region may also influence SNCA expression. By using cultured cells, we identified a region of the SNCA CpG island in which the methylation status altered along with increased SNCA expression. Postmortem brain analysis revealed regional non-specific methylation differences in this CpG region in the anterior cingulate and putamen among controls and PD; however, in the substantia nigra of PD, methylation was significantly decreased. This CpG region may function as an intronic regulatory element for SNCA gene. Our findings suggest that a novel epigenetic regulatory mechanism controlling SNCA expression influences PD pathogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O26:B6, γ-irradiated, BioXtra, suitable for cell culture